Neuropathic pain is a common problems for those suffering from Type 2 diabetes which is very difficult to treat and can make day to day activities unbearable.
However a new drug known as ARA 290 has been developed by Araim Pharmaceuticals. This drug activates receptors that switch off inflammation and powers the body’s natural repair system. The study involved patients taking ARA 290 for 28 days. Some patients were given ARA 290 whilst others recieved a placebo. Patient’s then answered a PainDetect questionaire which indicated a significant reduction in pain. The results indicated anti inflammtory tissue properties along with pain relief.
(Podiatry Now, 2015)